Antioxidants preserve vision in retina disease

Article

Consumption of antioxidants may enable retinal degeneration patients to preserve vision even while vascular abnormalities continue to exist, concluded a study published online ahead of print by the Journal of Clinical Investigation.

Consumption of antioxidants may enable retinal degeneration patients to preserve vision even while vascular abnormalities continue to exist, concluded a study published online ahead of print by the Journal of Clinical Investigation.

Professor Martin Friedlander, MD, PhD of Scripps Research Institute, US and colleagues examined mice with dysfunctional VLDL receptors, which imitate abnormal retinal neovascularisation associated with death of the photoreceptor cells in humans. Such symptoms are associated with conditions such as retinal angiomatous proliferation (RAP) and macular telangiectasia (MacTel).

The team found that abnormalities of the intraretinal vasculature and associated neuronal cell death were correlated with increased oxidative stress markers; there oxidative stress markers were mediated either by nutritional antioxidant supplements or by targeted topical antioxidant delivery, although the presence of antioxidants had no impact on the existing vascular abnormalities.

Therefore the researchers concluded that, by reducing oxidative stress, photoreceptor cells could be preserved and functional vision maintained by RAP and MacTel patients even while retinal vasculature is not improved.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Andreas Pollreisz, MD, discusses widefield OCT-A and fluorescence angiography at the 2025 European Society of Retina Specialists EURETINA meeting
Harvey Uy, MD, DPBO, FVRSP, speaks about artificial intelligence (AI) and optical coherence tomography (OCT) at the 2025 European Society of Retina Specialists (EURETINA) Congress.
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
© 2025 MJH Life Sciences

All rights reserved.